195 related articles for article (PubMed ID: 36345344)
1. Defining the origin, evolution, and immune composition of SDH-deficient renal cell carcinoma.
Neves JB; Roberts K; Nguyen JS; El Sheikh S; Tran-Dang MA; Horsfield C; Mumtaz F; Campbell P; Stauss H; Tran MGB; Mitchell T
iScience; 2022 Nov; 25(11):105389. PubMed ID: 36345344
[TBL] [Abstract][Full Text] [Related]
2. Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
Williamson SR; Eble JN; Amin MB; Gupta NS; Smith SC; Sholl LM; Montironi R; Hirsch MS; Hornick JL
Mod Pathol; 2015 Jan; 28(1):80-94. PubMed ID: 25034258
[TBL] [Abstract][Full Text] [Related]
3. SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response.
McEvoy CR; Koe L; Choong DY; Leong HS; Xu H; Karikios D; Plew JD; Prall OW; Fellowes AP; Fox SB
NPJ Precis Oncol; 2018; 2():9. PubMed ID: 29872718
[TBL] [Abstract][Full Text] [Related]
4. Hereditary succinate dehydrogenase-deficient renal cell carcinoma.
Rogala J; Zhou M
Semin Diagn Pathol; 2024 Jan; 41(1):32-41. PubMed ID: 37981479
[TBL] [Abstract][Full Text] [Related]
5. [Succinate dehydrogenase (SDH)-deficient renal cell carcinoma].
Agaimy A
Pathologe; 2016 Mar; 37(2):144-52. PubMed ID: 26979428
[TBL] [Abstract][Full Text] [Related]
6. Succinate Dehydrogenase-Deficient Renal Cancer Featuring Fructose-1,6-Biphosphatase Loss, Pyruvate Kinase M2 Overexpression, and SWI/SNF Chromatin Remodeling Complex Aberrations: A Rare Case Report.
Szymanski M; Rusetska N; Jancewicz I; Armatowska A; Ligaj M; Chrzan A; Hincza K; Kowalik A; Mika P; Kisiel M; Zolnierek J; Kosior J; Demkow T; Siedlecki JA; Sarnowski TJ; Sarnowska E
Oncologist; 2021 Sep; 26(9):e1652-e1655. PubMed ID: 34003534
[TBL] [Abstract][Full Text] [Related]
7. Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients.
Gill AJ; Hes O; Papathomas T; Šedivcová M; Tan PH; Agaimy A; Andresen PA; Kedziora A; Clarkson A; Toon CW; Sioson L; Watson N; Chou A; Paik J; Clifton-Bligh RJ; Robinson BG; Benn DE; Hills K; Maclean F; Niemeijer ND; Vlatkovic L; Hartmann A; Corssmit EP; van Leenders GJ; Przybycin C; McKenney JK; Magi-Galluzzi C; Yilmaz A; Yu D; Nicoll KD; Yong JL; Sibony M; Yakirevich E; Fleming S; Chow CW; Miettinen M; Michal M; Trpkov K
Am J Surg Pathol; 2014 Dec; 38(12):1588-602. PubMed ID: 25025441
[TBL] [Abstract][Full Text] [Related]
8. Hand-Assisted Laparoscopic Partial Nephrectomy for Large Renal Carcinoma with Succinate Dehydrogenase Deficiency.
Bersang AB; Bube S; Fode M; Azawi NH
J Endourol Case Rep; 2018; 4(1):12-14. PubMed ID: 29450259
[No Abstract] [Full Text] [Related]
9. Adolescent male with bilateral succinate dehydrogenase-deficient renal cell carcinoma in a horseshoe kidney managed successfully with staged bilateral robotic-assisted partial nephrectomies: A case report.
Pulford C; Keating K; Eames R; Holdren C; Peifer D; Maatman T
Urol Case Rep; 2023 Jul; 49():102412. PubMed ID: 37275562
[TBL] [Abstract][Full Text] [Related]
10. Genomic and Metabolic Hallmarks of SDH- and FH-deficient Renal Cell Carcinomas.
Yoo A; Tang C; Zucker M; Fitzgerald K; DiNatale RG; Rappold PM; Weiss K; Freeman B; Lee CH; Schultz N; Motzer R; Russo P; Coleman J; Reuter VE; Chen YB; Carlo MI; Gill AJ; Kotecha RR; Ari Hakimi A; Reznik E
Eur Urol Focus; 2022 Sep; 8(5):1278-1288. PubMed ID: 35288096
[TBL] [Abstract][Full Text] [Related]
11. Succinate dehydrogenase deficient renal cell carcinoma: A case report.
Kumar RA; Miyagi H; Mittal V; Crispen P; Kumar U
Urol Case Rep; 2022 Jan; 40():101885. PubMed ID: 34712582
[TBL] [Abstract][Full Text] [Related]
12. Incidence of succinate dehydrogenase and fumarate hydratase-deficient renal cell carcinoma based on immunohistochemical screening with SDHA/SDHB and FH/2SC.
Gupta S; Swanson AA; Chen YB; Lopez T; Milosevic D; Kipp BR; Leibovich BC; Thompson RH; Herrera-Hernandez L; Cheville JC; Jimenez RE
Hum Pathol; 2019 Sep; 91():114-122. PubMed ID: 31299266
[TBL] [Abstract][Full Text] [Related]
13. Renal carcinoma associated with a novel succinate dehydrogenase A mutation: a case report and review of literature of a rare subtype of renal carcinoma.
Ozluk Y; Taheri D; Matoso A; Sanli O; Berker NK; Yakirevich E; Balasubramanian S; Ross JS; Ali SM; Netto GJ
Hum Pathol; 2015 Dec; 46(12):1951-5. PubMed ID: 26476567
[TBL] [Abstract][Full Text] [Related]
14. Succinate dehydrogenase-deficient malignant paraganglioma complicated by succinate dehydrogenase-deficient renal cell carcinoma.
Yamaguchi Y; Yokoyama M; Takemoto A; Nakamura Y; Fukuda S; Uehara S; Tanaka H; Yoshida S; Matsuoka Y; Fujii Y
IJU Case Rep; 2022 Nov; 5(6):480-483. PubMed ID: 36341179
[TBL] [Abstract][Full Text] [Related]
15. Inactivation of SDH and FH cause loss of 5hmC and increased H3K9me3 in paraganglioma/pheochromocytoma and smooth muscle tumors.
Hoekstra AS; de Graaff MA; Briaire-de Bruijn IH; Ras C; Seifar RM; van Minderhout I; Cornelisse CJ; Hogendoorn PC; Breuning MH; Suijker J; Korpershoek E; Kunst HP; Frizzell N; Devilee P; Bayley JP; Bovée JV
Oncotarget; 2015 Nov; 6(36):38777-88. PubMed ID: 26472283
[TBL] [Abstract][Full Text] [Related]
16. Current management of succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Neppala P; Banerjee S; Fanta PT; Yerba M; Porras KA; Burgoyne AM; Sicklick JK
Cancer Metastasis Rev; 2019 Sep; 38(3):525-535. PubMed ID: 31773431
[TBL] [Abstract][Full Text] [Related]
17. Succinate dehydrogenase deficient gastrointestinal stromal tumors (GISTs) - a review.
Miettinen M; Lasota J
Int J Biochem Cell Biol; 2014 Aug; 53():514-9. PubMed ID: 24886695
[TBL] [Abstract][Full Text] [Related]
18. A distinctive, low-grade oncocytic fumarate hydratase-deficient renal cell carcinoma, morphologically reminiscent of succinate dehydrogenase-deficient renal cell carcinoma.
Smith SC; Sirohi D; Ohe C; McHugh JB; Hornick JL; Kalariya J; Karia S; Snape K; Hodgson SV; Cani AK; Hovelson D; Luthringer DJ; Martignoni G; Chen YB; Tomlins SA; Mehra R; Amin MB
Histopathology; 2017 Jul; 71(1):42-52. PubMed ID: 28165631
[TBL] [Abstract][Full Text] [Related]
19. Functional deficiency of succinate dehydrogenase promotes tumorigenesis and development of clear cell renal cell carcinoma through weakening of ferroptosis.
Yang J; Zhou Y; Li Y; Hu W; Yuan C; Chen S; Ye G; Chen Y; Wu Y; Liu J; Wang Y; Du J; Tong X
Bioengineered; 2022 Apr; 13(4):11187-11207. PubMed ID: 35510387
[TBL] [Abstract][Full Text] [Related]
20. Succinate Dehydrogenase-Deficient Renal Cell Carcinoma: A Short Review.
Wang G; Rao P
Arch Pathol Lab Med; 2018 Oct; 142(10):1284-1288. PubMed ID: 30281364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
